Europe Neutropenia Treatment Market By Distribution channel (Retail pharmacies, Hospital pharmacies and Online pharmacies), By Treatment (Colony-stimulating factor, Antibiotics, Antifungals and Antivirals), By Country, Industry Analysis and Forecast, 2020 - 2026
The Europe Neutropenia Treatment Market would witness market growth of 6.2% CAGR during the forecast period (2020-2026).
Neutropenia occurs when a person has low levels of neutrophils, a type of white blood cell. Neutrophils are formed in the bone marrow, which is the spongy tissue contained in larger bones, such as the vertebrae, ribs, and pelvis. White blood cells help the body battle infections. Neutrophils fight infection by removing toxic fungi, yeast, and bacteria that invade the body. People with neutropenia are at greater risk of contracting severe infections. Half of the cancer patients undergoing chemotherapy experience a level of neutropenia. Neutropenia is a common side effect in people with leukemia.
Growing cases of leukemia across the globe and a shift tthe use of biosimilars from branded drugs in cancer-supporting treatment are driving the growth of the global neutropenia treatment market. Nevertheless, the high cost of treatment associated with neutropenia and the strict government regulations for product approval reduce the growth of the market. On the other hand, the increase in R&D activities for the development of new drugs creates new opportunities for market players in the coming years.
Novel treatments combined with growing cases of chemotherapy-induced neutropenia are one of the primary drivers of market growth. In addition, the novel drug delivery strategy alsincreases patient convenience, leading tgreater adherence tthe patient and thereby stimulates the growth of the market. Moreover, since cancer is a known cause of developing neutropenia, increasing cases of chemotherapy for cancer treatment will be a growth driver for the neutropenia treatment market.
Based on Distribution channel, the market is segmented intRetail pharmacies, Hospital pharmacies and Online pharmacies. Based on Treatment, the market is segmented intColony-stimulating factor, Antibiotics, Antifungals and Antivirals. Based on countries, the market is segmented intGermany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amgen, Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., BeyondSpring, Inc., Spectrum Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd. (Kirin Company), Mylan N.V., Cellerant Therapeutics, Inc., and Partner Therapeutics, Inc.
Scope of the Study
By Distribution Channel
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook